127 filings
Page 4 of 7
8-K
4a89xt6
24 Dec 14
Other Events
12:00am
8-K
o3h5k6sbedeyxre
16 Dec 14
Entry into a Material Definitive Agreement
12:00am
8-K
ce1wv99rw6ivqub8fjh8
21 Nov 14
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
udd8tu
14 Nov 14
Anthera Pharmaceuticals Reports 2014 Third Quarter Financial Results
12:00am
8-K
75s0hi
23 Oct 14
Termination of a Material Definitive Agreement
12:00am
8-K
4wplcok
1 Oct 14
Anthera Pharmaceuticals Announces Update on Strategic Partnership Discussions for Blisibimod
12:00am
8-K
6p2gf
29 Jul 14
Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results
12:00am
8-K
8p0nxaa ip3k
17 Jul 14
Anthera Pharmaceuticals Announces Acquisition of Sollpura® (liprotamase) for Exocrine Pancreatic Insufficiency From Eli Lilly and Company
12:00am
8-K
z5z8o rwm
23 Jun 14
Anthera Pharmaceuticals Appoints Brian R. Mueller to Board of Directors
12:00am
8-K
j80v5 baj7v
13 Jun 14
Anthera Pharmaceuticals Appoints Dr. Philip Sager to Board of Directors
12:00am
8-K
mkmjb27azbz m3
13 May 14
Anthera Pharmaceuticals Reports 2014 First Quarter Financial Results
12:00am
8-K
lri6mzxv9hl
31 Mar 14
Departure of Directors or Certain Officers
12:00am
8-K
y5rwi1g7
12 Mar 14
Anthera Pharmaceuticals Reports 2013 Fourth Quarter And Fiscal Year Financial Results
12:00am
8-K
mr5044kf
23 Dec 13
Departure of Directors or Certain Officers
12:00am
8-K
zz7zl
15 Nov 13
Entry into a Material Definitive Agreement
12:00am
8-K
zogyp bmmztb
29 Oct 13
Clinical and Regulatory Update
12:00am
8-K
1q5a 5nipz9
4 Sep 13
Changes in Registrant's Certifying Accountant
12:00am
8-K
pwo0oz5ac8mq5 5y
30 Jul 13
Anthera Pharmaceuticals Reports 2013 Second Quarter Financial Results
12:00am
8-K
iu5tr5x tz7v
16 Jul 13
Anthera Pharmaceuticals Announces 1-for-8 Reverse Split of Stock
12:00am
8-K
fedujbf6wiph 07
24 Jun 13
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am